Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

Less is more: how risk-based monitoring is changing trials

A quality risk management approach is one of the biggest drivers for change in clinical research

- PMLiVE

AZ confirms interest in Acerta takeover

Possible acquisition of Netherlands-based cancer drug developer may be worth more than $5bn

- PMLiVE

NICE backs Xtandi but turns down Zytiga

Astellas and Medivation's pre-chemotherapy prostate cancer drug receives support

Roche Basel Switzerland

Roche’s lung cancer drug Alecensa gets FDA OK

Wins accelerated US approval for non-small cell lung cancer

Centralized marketing with local market relevance: The big challenge for Pharma HQ marketers

There are good reasons for wanting to centralize and control marketing content: it reduces duplication of work, saves money and time, and also ensures a consistent level of quality. With...

Anthill Agency

- PMLiVE

Communicating the prevention message by Tam Fry

Tam Fry, spokesperson of the National Obesity Forum, discusses how prevention is key to tackling the childhood obesity epidemic in the UK.

Say Communications

- PMLiVE

Barry Labinger joins Biothera Pharmaceutical

Brings experience from Human Genome Sciences and 3M Pharmaceuticals

EU flag

Public-private partnerships ‘making a difference’ in Europe

One of those is the IMI, which has helped drug development bottlenecks

- PMLiVE

ArchiMed acquires life sciences consultancy Deallus

Healthcare private equity firm is also looking at a number of 'bolt-on' deals

- PMLiVE

Health4Brands makes trio of new appointments

Davide Maga returns to its London office and Natalie Saunders and Emma Marsh join

Deal Watch November 2015

Strategic business expansion or financial engineering?In November Pfizer at long last found a willing acquisition target that may provide the tax inversion it has been desperate to achieve since its...

UCB trials wearable sensor for Parkinson’s

Its medical device combines with a mobile app to measure motor symptom patterns

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links